Comparison of the Development Model of DTP Pharmacy between China and the United States and Its Enlightenment

Abstract

Objective To systematically analyze the development status of DTP pharmacy in the United States and China, and to find out the problems in China’s DTP pharmacy and put forward some countermeasures and suggestions. Methods Relevant literature was searched and reviewed to study the history, market scale and development trend of DTP pharmacy in the United States and China. Then, the problems in China’s DTP pharmacy were found out. Results and Conclusion DTP pharmacy model in the U.S. has taken shape and is maturing. The high degree of industry concentration is an important feature of the U.S. pharmacy. In contrast, China’s DTP pharmacy started late, and the industry pattern has not yet been finalized. There are still some problems in the DTP pharmacy certification and quality management. It is recommended to promote the rapid development of DTP pharmacies in China by encouraging the outflow of prescription drugs, establishing a third-party pharmacy accreditation organization and strengthening the team of licensed pharmacists and other personnel.

Keywords

DTP pharmacy / specialty pharmacy / development model / policy implication

References

[1] Chen Jia. An overview of the current situation, prospects and suggestions for the development of DTP pharmacy[J]. Straits Pharmacy, 2023, 35 (3): 100-102.

[2] Wang Jinyin. DTP pharmacy, welcome the best development era[J]. China Pharmacy, 2019 (7): 80-81.

[3] Yang Xianhui, Zhang Xiaoxia. SWOT analysis and development suggestions of DTP pharmacy in China[J]. China Pharmaceutical Affairs, 2015, 29 (3): 329-332.

[4] Zhou Xiang, Chen Chaoran. Analysis of the development process and reasons of DTP pharmacy in China[J]. China Health Industry, 2019, 16 (19): 191-193.

[5] Lu Jing. Research on the development strategy of DTP pharmacy chain of SC Pharmaceutical Co,. Ltd.[D]. University of Electronic Science and Technology of China, 2022.

[6] Gao Hongyang. Specialized pharmacies growing at a fast pace as policies and markets work together 2022-2023 report on the development of specialized pharmacies in Chinese pharmacies[J]. China Pharmacy, 2023 (4): 114-124.

[7] Gao Hongyang. Specialty pharmacy in the United States in 2022: Vertical integration and increasing monopoly[J]. China Pharmacy, 2023 (4): 130-133.

[8] Qian Zhenguang, Wang Yanyan, Zhu Yanjiao, et al. Study on the extension of DTP pharmacy model in China under the background of medicine separation[J]. China Health Service Management, 2019, 36 (5): 357-359+369.

[9] Zhong Yuanyuan. The attack of American specialty pharmacy[J]. China Pharmacy, 2021 (10): 60-62.

[10] Hu Jun, Xue Lijun, Shao Rong. Research on specialty pharmacy in the United States and its inspiration to DTP pharmacy in China[J]. Health Economics Research, 2018 (11): 31-34.

[11] Zhao Heng. Commercial insurance layout DTP trend, what is the potential for performance driven?[N]. Pharmaceutical Economic News, 2021-12-09 (B04).

[12] Zhang Xinrong, Yu Baorong. A study of the drug benefit management system in the United States and its implications[J]. Health Economics Research, 2021, 38 (8): 53-58.

[13] Gao Hongyang. Specialty pharmacy market in the United States: Challenging more uncharted space[J]. China Pharmacy, 2018 (12): 70-72.

[14] Zhong Yuanyuan. US pharmaceutical retailers lay out specialty pharmacies, each excelling in its own way[J]. China Pharmacy, 2020 (12): 69-71.

[15] Jiang Rong, Wang Yinuo, Zhu Jingjing, et al. Quality management system of US specialized pharmacies and its inspiration to the management of dual-channel pharmacies in China[J]. China Health Service Management, 2022, 39 (3): 185-189+220.

[16] Zhang Song. Three real-world experiences upgrading specialized pharmacies with transformation and innovation[N]. Pharmaceutical Economic News, 2021-08-12 (B01).